Positively Sharing

NHS England extends anti-HIV drug trial, but Camden councillor says roll-out doesn’t go far enough

Reading Time: < 1 minute
Truvada, a example of the PrEP preventative-HIV drug. Picture: Creative Commons/Jeffrey Beall

Truvada, a example of the PrEP preventative-HIV drug. Picture: Creative Commons/Jeffrey Beall

This morning NHS England announced there would be 4,000 more places on the PrEP trial in London.

The expansion, which will take place over the next few weeks, represents a 60 per cent increase in the trial places available. London already accounts for 7,609 places, higher than the rest of England combined. Read More

Exit mobile version